Opportunity Information: Apply for RFA DA 22 005
The National Institutes of Health (NIH) funding opportunity announcement RFA-DA-22-005, titled "Mechanistic studies on the impact of social inequality on the substance use trajectory (R21 - Clinical Trial Not Allowed)," supports early-stage, exploratory research aimed at explaining how socioeconomic inequality gets "under the skin" to influence substance use and related outcomes. The central focus is on neurocognitive mechanisms, meaning applicants are expected to move beyond documenting that inequality and substance use are linked and instead test plausible pathways involving brain, cognition, and related behavioral processes that could explain why and how inequality changes risk across the course of substance use.
This opportunity is structured as an NIH R21 mechanism, which is typically used for high-impact, innovative, and developmental projects where investigators may be piloting new ideas, measures, datasets, or analytic strategies. The FOA specifically indicates that clinical trials are not allowed, so proposed work should not be designed as an intervention trial or a clinical trial to test treatment efficacy. Instead, the emphasis is on mechanistic and observational or experimental-laboratory style research that clarifies underlying processes. The announcement highlights interest in "various points in the substance use trajectory," which generally refers to stages such as initiation of use, escalation, maintenance, progression to problematic use or substance use disorder, relapse, recovery, and other transitions over time. Projects can target one stage or examine multiple stages, as long as the mechanistic question is clear and the approach is well matched to it.
The scientific theme centers on socioeconomic inequality as a driver of neurocognitive risk. In practice, this can include factors such as poverty, income instability, neighborhood disadvantage, housing insecurity, limited access to education and opportunity, and broader structural inequities that shape daily stress exposure and access to resources. The FOA is interested in how these inequality-related exposures may alter neurocognitive systems relevant to substance use, for example decision-making under uncertainty, reward sensitivity, stress reactivity, impulse control, learning and habit formation, emotion regulation, executive function, attentional bias, and cognitive control. The intended result is a clearer, testable explanation of how social conditions translate into changes in cognition and brain-related function that, in turn, shape real-world substance use behaviors and outcomes.
From an administrative standpoint, this is a discretionary grant opportunity in the health area (CFDA 93.279) administered by NIH. The listing provides an award ceiling of $200,000. The original closing date shown in the source data is 2021-10-14, and the FOA was created on 2021-05-24. The source data does not specify the number of expected awards, but the announcement is presented as a competitive NIH funding opportunity.
A wide range of applicant organizations are eligible. In addition to common eligible entities such as state, county, city or township governments, special district governments, independent school districts, and public housing authorities/Indian housing authorities, the FOA allows applications from public and state-controlled institutions of higher education, private institutions of higher education, and Native American tribal governments (federally recognized). It also welcomes nonprofit organizations both with and without 501(c)(3) status (other than institutions of higher education), for-profit organizations (other than small businesses), and small businesses. The FOA also explicitly names additional eligible applicant categories that NIH encourages to apply, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), Indian/Native American Tribal Governments (other than federally recognized), faith-based or community-based organizations, eligible federal agencies, U.S. territories or possessions, regional organizations, and non-domestic (non-U.S.) entities (foreign organizations). Taken together, the eligibility language signals an interest in broad participation, including institutions and communities that are often closest to populations experiencing the greatest burden of socioeconomic inequality and substance-related harms.
Overall, this FOA funds research that connects social inequality to substance use through measurable neurocognitive processes, aiming to produce mechanistic insights that can later guide prevention, policy, and future intervention development, without conducting a clinical trial within this specific R21 announcement.Apply for RFA DA 22 005
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Mechanistic studies on the impact of social inequality on the substance use trajectory (R21 - Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
- This funding opportunity was created on 2021-05-24.
- Applicants must submit their applications by 2021-10-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the funding opportunity?
This opportunity is the National Institutes of Health (NIH) Funding Opportunity Announcement (FOA) RFA-DA-22-005, titled "Mechanistic studies on the impact of social inequality on the substance use trajectory (R21 - Clinical Trial Not Allowed)."
What is the main purpose of this FOA?
The FOA supports early-stage, exploratory research designed to explain how socioeconomic inequality can influence substance use and related outcomes through measurable neurocognitive mechanisms. The intent is to move beyond showing that inequality and substance use are linked and instead test plausible pathways that explain why and how inequality changes risk across the substance use trajectory.
What kind of research does NIH want to fund under this announcement?
The emphasis is on mechanistic studies focused on neurocognitive processes (brain-, cognition-, and behavior-related mechanisms) that may connect inequality-related exposures to substance use behaviors and outcomes. The projects are expected to test pathways rather than only document associations.
What does "Mechanistic studies" mean in this context?
In this FOA, "mechanistic" means the project should evaluate specific, testable explanations for how social inequality gets "under the skin" and affects substance use risk. This typically involves examining measurable neurocognitive functions and related behavioral processes that could reasonably explain changes in substance use patterns over time.
What does "social inequality" refer to for this opportunity?
The FOA frames socioeconomic inequality broadly, including factors such as poverty, income instability, neighborhood disadvantage, housing insecurity, limited access to education and opportunity, and broader structural inequities that influence stress exposure and access to resources.
What is meant by the "substance use trajectory"?
The substance use trajectory generally refers to stages and transitions such as initiation of use, escalation, maintenance, progression to problematic use or substance use disorder, relapse, recovery, and other changes over time. Projects may focus on one stage or multiple stages, as long as the mechanistic question is clear.
Does the project have to cover the entire substance use trajectory?
No. The FOA indicates interest at "various points" in the trajectory. A project can target a single stage (for example, initiation or relapse) or examine multiple stages, provided the mechanistic focus and approach are well aligned.
What kinds of neurocognitive mechanisms are of interest?
The FOA highlights neurocognitive systems relevant to substance use, including decision-making under uncertainty, reward sensitivity, stress reactivity, impulse control, learning and habit formation, emotion regulation, executive function, attentional bias, and cognitive control.
Is this opportunity meant for exploratory or later-stage research?
It is intended for early-stage, exploratory research. The FOA uses the NIH R21 mechanism, which typically supports high-impact, innovative, and developmental projects that may pilot new ideas, measures, datasets, or analytic strategies.
What is the grant mechanism used in this FOA?
This FOA uses the NIH R21 mechanism.
Are clinical trials allowed under this FOA?
No. The FOA explicitly states "Clinical Trial Not Allowed," so the proposed work should not be designed as an intervention trial or a clinical trial to test treatment efficacy.
If clinical trials are not allowed, what types of study approaches fit this FOA?
Based on the FOA description, the emphasis is on mechanistic research that clarifies underlying processes. This aligns with mechanistic observational approaches or experimental-laboratory style research designs that test neurocognitive pathways without being a clinical trial.
What is the award ceiling listed for this opportunity?
The listing provides an award ceiling of $200,000.
Which federal agency administers this funding opportunity?
The opportunity is administered by the National Institutes of Health (NIH).
What is the CFDA number associated with this opportunity?
The listing identifies CFDA 93.279.
When was this FOA created?
The source data states the FOA was created on 2021-05-24.
What is the closing date shown in the source data?
The original closing date shown is 2021-10-14.
How many awards does NIH expect to make under this FOA?
The source data provided does not specify the number of expected awards. The announcement is presented as a competitive NIH funding opportunity.
Who is eligible to apply?
The FOA includes a wide range of eligible applicants, including (as listed in the provided information): state, county, city or township governments; special district governments; independent school districts; public housing authorities/Indian housing authorities; public and state-controlled institutions of higher education; private institutions of higher education; Native American tribal governments (federally recognized); nonprofit organizations with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); and small businesses.
Are institutions like HBCUs, HSIs, and Tribal Colleges included in eligibility?
Yes. The FOA explicitly names and encourages applications from categories including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), and other serving institutions described in the announcement.
Are faith-based or community-based organizations eligible?
Yes. The FOA explicitly includes faith-based or community-based organizations among the eligible applicant categories named in the provided information.
Are non-U.S. (foreign) organizations eligible to apply?
Yes. The FOA explicitly includes non-domestic (non-U.S.) entities (foreign organizations) as eligible applicants in the provided information.
Are U.S. territories or possessions included as eligible applicants?
Yes. The FOA explicitly mentions U.S. territories or possessions among eligible applicant categories.
Can for-profit organizations apply?
Yes. The FOA includes for-profit organizations (other than small businesses) and also includes small businesses as eligible applicants.
Is this a discretionary grant opportunity?
Yes. The provided information describes it as a discretionary grant opportunity in the health area.
What is the key scientific expectation for applications?
The key expectation is that applicants go beyond documenting a link between inequality and substance use and instead test plausible neurocognitive pathways that explain how inequality-related exposures translate into changes in cognition and brain-related function that shape substance use behaviors and outcomes.
What is the intended impact of research funded under this FOA?
The intended result is mechanistic insight: clearer, testable explanations of how social conditions influence substance use via neurocognitive processes. The FOA notes that such insights can later inform prevention, policy, and future intervention development, even though clinical trials are not part of this specific announcement.
Browse more opportunities from the same category: Education, Health
Next opportunity: Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Basic Experimental Studies with Humans Required (BESH))
Previous opportunity: AK-21-02: Synthesis of Contaminants Data for Cook Inlet: Evaluation of Existing Data as “Baseline Conditions” and Recommendations for Further Monitoring
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 22 005
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 22 005) also looked into and applied for these:
| Funding Opportunity |
|---|
| Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Basic Experimental Studies with Humans Required) Apply for RFA DA 22 024 Funding Number: RFA DA 22 024 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R21 - Basic Experimental Studies with Humans Required) Apply for RFA DA 22 030 Funding Number: RFA DA 22 030 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Assessing the Effects of Cannabinoids on HIV-Associated Persistent Inflammation (R01 Clinical Trial Optional) Apply for RFA DA 22 012 Funding Number: RFA DA 22 012 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional) Apply for RFA CA 21 033 Funding Number: RFA CA 21 033 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| The Early Detection Research Network: Data Management and Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA CA 21 034 Funding Number: RFA CA 21 034 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed) Apply for RFA CA 21 035 Funding Number: RFA CA 21 035 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional) Apply for PAR 21 138 Funding Number: PAR 21 138 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploratory Studies to Investigate the Mechanisms of Interrelationship Between Sleep and Substance Use Disorders (R61/R33 Clinical Trials Not Allowed) Apply for RFA DA 22 016 Funding Number: RFA DA 22 016 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Data Analysis Resource (U24 Clinical Trials Optional) Apply for RFA AA 21 009 Funding Number: RFA AA 21 009 Agency: National Institutes of Health Category: Education, Health Funding Amount: $600,000 |
| Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Research Project Sites (U01 Clinical Trials Optional) Apply for RFA AA 21 007 Funding Number: RFA AA 21 007 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Administrative Resource (U24 Clinical Trials Optional) Apply for RFA AA 21 008 Funding Number: RFA AA 21 008 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| NIDA Animal Genomics Program (U01 Clinical Trial Not Allowed) Apply for PAR 21 244 Funding Number: PAR 21 244 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Innovative Models for Delivering PrEP and STI Services to Stop HIV in the United States (R61/R33 Clinical Trial Optional) Apply for RFA AI 20 069 Funding Number: RFA AI 20 069 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| PrEP for HIV Prevention among Substance Using Populations (R01 - Clinical Trial Optional) Apply for RFA DA 22 017 Funding Number: RFA DA 22 017 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Organoid Modeling of Neural Stimulants and HIV Comorbidity of Human Brain (R01- Clinical Trial Optional) Apply for RFA DA 22 009 Funding Number: RFA DA 22 009 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Large Scale Mapping and/or Molecular Profiling of Ensembles and/or Cell-Types Mediating Opioid Action in the Rodent Brain (R01 - Clinical Trial Not Allowed) Apply for RFA DA 22 011 Funding Number: RFA DA 22 011 Agency: National Institutes of Health Category: Education, Health Funding Amount: $700,000 |
| Elucidating the Effects of ART on Neuronal Function in the Context of SUD and HIV (R01 - Clinical Trials Not Allowed) Apply for RFA DA 22 003 Funding Number: RFA DA 22 003 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required) Apply for RFA CA 21 040 Funding Number: RFA CA 21 040 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Understanding Oral Human Papillomavirus (HPV) Infection, Acquisition, and Persistence in People Living with HIV (R21 Clinical Trial Not Allowed) Apply for RFA DE 22 004 Funding Number: RFA DE 22 004 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Program on the Origins of Gastroesophageal Cancers (R01 Clinical Trial Optional) Apply for RFA CA 21 026 Funding Number: RFA CA 21 026 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 22 005", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.